People at high risk of cancer of the bowel and womb due to a genetic condition will receive a more accurate diagnosis as a result of a new model developed by a team of international scientists.
A scientist from the University's Institute of Medical Genetics, School of Medicine, is part of an international research team who have developed this new way of identifying people at high risk of cancer.
The research, published in the journal Nature Genetics, focuses on the genes responsible for Lynch Syndrome - an inherited, familial condition that increases the risk of bowel, womb and other cancers, especially at a young age. About 5% of bowel and womb cancers are thought to be due to Lynch Syndrome.
The model essentially turns previously uninterpretable DNA data into usable knowledge with a direct clinical benefit. It means doctors worldwide can now access new information and give patients a truer picture of their familial risk.
"In the UK, bowel cancer kills about 16,000 people each year, and womb cancer - the commonest gynaecological cancer - about 2,000 women a year, with Wales having the highest rate," according to Dr Ian Frayling, School of Medicine, member of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) which organised the research.
"What we have been able to do is effectively refine genetic information in the InSiGHT database and provide a more accurate answer of the risk of getting cancer," he added.
Patients who currently have genetic testing for Lynch Syndrome are often told they have 'variants of uncertain significance' which is an inconclusive result.
People are left in a kind of genetic limbo, unsure of whether they face a high risk of cancer, or whether their family members are also at risk.
"As a result of this work, doctors will now be able to say much more confidently whether those patients have Lynch Syndrome, and therefore whether they are at a higher risk of cancer," according to Dr Frayling.
"This will help to save more lives, because by giving a definite answer to more patients, they will be able to access the specialist screening that they need.
"It will also save NHS resources and be safer, because we will be able to reassure people that they are not at risk and so don't need the extra screening. As a result of this, colleagues and the families they care for all over the UK are now benefitting, and we are working on incorporating this into the UK Guidelines on testing for Lynch Syndrome," he adds.
Explore further: Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome
Medical Xpress on facebook
Related Stories
Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome
Dec 11, 2013
A recent article by Norris Cotton Cancer Center researchers published in the January 2014 issue of the journal Clinical Chemistry reviews the scientific evidence that warrants screening all endometrial cancers for Lynch ...
Despite good prognosis, some turn a blind eye to genetic screening
Jun 03, 2013
Even if Australians with newly diagnosed bowel cancer were routinely tested for a genetic predisposition to further cancers, one in three people would still not take the necessary steps to use that information to prevent ...
Prostate cancer risk rises in men with inherited genetic condition
Apr 01, 2013
Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study led by ...
Scientists prove regular aspirin intake halves cancer risk
Oct 28, 2011
Scientists including those from Queen's University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.
Researchers develop clinical screening program for no.1 genetic cause of colon cancer
Feb 14, 2013
(Medical Xpress)—Cleveland Clinic researchers have found that colorectal cancer outcomes could be improved with regular genetic screening for Lynch syndrome, the most common hereditary, adult-onset cause of colorectal cancer, ...
Recommended for you
Genetic screening identifies genes driving resistance with a guide RNA library
14 hours ago
Researchers have developed a method to create a comprehensive library of mutations across all genes in the mouse genome. This library can be used to examine the role of every gene in different cell types.
Gene that influences the ability to remember faces found
17 hours ago
New findings suggest the oxytocin receptor, a gene known to influence mother-infant bonding and pair bonding in monogamous species, also plays a special role in the ability to remember faces. This research has important implications ...
Explainer: What is heritability?
22 hours ago
Schizophrenia, depression, bipolar disorder and autism have all had recent attention for being "genetically caused". ...
Genetics that protects your heart
22 hours ago
(Medical Xpress)—Researchers have found a key piece of the puzzle as to why an isolated population in Greece may live healthy lives. They have found that a genetic variant known to protect the heart is ...
Genetic profiling tracks progression from manageable blood cancer into deadly disease
22 hours ago
Genetic profiling has painted the clearest picture yet of how a type of blood cancer – follicular lymphoma – develops and changes from a manageable disease into an aggressive cancer, offering new targets ...
Nonsense suppression drug restores function in a mouse model of aniridia
Dec 20, 2013
Congenital aniridia is a progressive disease that is associated with improper development of eye structures as well as abnormalities in the brain and pancreas. A variety of nonsense mutations in the PAX6 gene are linked with a ...
User comments
© Medical Xpress 2011-2013, Science X network
People at high risk of cancer of the bowel and womb due to a genetic condition will receive a more accurate diagnosis as a result of a new model developed by a team of international scientists.
A scientist from the University's Institute of Medical Genetics, School of Medicine, is part of an international research team who have developed this new way of identifying people at high risk of cancer.
The research, published in the journal Nature Genetics, focuses on the genes responsible for Lynch Syndrome - an inherited, familial condition that increases the risk of bowel, womb and other cancers, especially at a young age. About 5% of bowel and womb cancers are thought to be due to Lynch Syndrome.
The model essentially turns previously uninterpretable DNA data into usable knowledge with a direct clinical benefit. It means doctors worldwide can now access new information and give patients a truer picture of their familial risk.
"In the UK, bowel cancer kills about 16,000 people each year, and womb cancer - the commonest gynaecological cancer - about 2,000 women a year, with Wales having the highest rate," according to Dr Ian Frayling, School of Medicine, member of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) which organised the research.
"What we have been able to do is effectively refine genetic information in the InSiGHT database and provide a more accurate answer of the risk of getting cancer," he added.
Patients who currently have genetic testing for Lynch Syndrome are often told they have 'variants of uncertain significance' which is an inconclusive result.
People are left in a kind of genetic limbo, unsure of whether they face a high risk of cancer, or whether their family members are also at risk.
"As a result of this work, doctors will now be able to say much more confidently whether those patients have Lynch Syndrome, and therefore whether they are at a higher risk of cancer," according to Dr Frayling.
"This will help to save more lives, because by giving a definite answer to more patients, they will be able to access the specialist screening that they need.
"It will also save NHS resources and be safer, because we will be able to reassure people that they are not at risk and so don't need the extra screening. As a result of this, colleagues and the families they care for all over the UK are now benefitting, and we are working on incorporating this into the UK Guidelines on testing for Lynch Syndrome," he adds.
Explore further: Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome
Medical Xpress on facebook
Related Stories
Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome
Dec 11, 2013
A recent article by Norris Cotton Cancer Center researchers published in the January 2014 issue of the journal Clinical Chemistry reviews the scientific evidence that warrants screening all endometrial cancers for Lynch ...
Despite good prognosis, some turn a blind eye to genetic screening
Jun 03, 2013
Even if Australians with newly diagnosed bowel cancer were routinely tested for a genetic predisposition to further cancers, one in three people would still not take the necessary steps to use that information to prevent ...
Prostate cancer risk rises in men with inherited genetic condition
Apr 01, 2013
Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study led by ...
Scientists prove regular aspirin intake halves cancer risk
Oct 28, 2011
Scientists including those from Queen's University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.
Researchers develop clinical screening program for no.1 genetic cause of colon cancer
Feb 14, 2013
(Medical Xpress)—Cleveland Clinic researchers have found that colorectal cancer outcomes could be improved with regular genetic screening for Lynch syndrome, the most common hereditary, adult-onset cause of colorectal cancer, ...
Recommended for you
Genetic screening identifies genes driving resistance with a guide RNA library
14 hours ago
Researchers have developed a method to create a comprehensive library of mutations across all genes in the mouse genome. This library can be used to examine the role of every gene in different cell types.
Gene that influences the ability to remember faces found
17 hours ago
New findings suggest the oxytocin receptor, a gene known to influence mother-infant bonding and pair bonding in monogamous species, also plays a special role in the ability to remember faces. This research has important implications ...
Explainer: What is heritability?
22 hours ago
Schizophrenia, depression, bipolar disorder and autism have all had recent attention for being "genetically caused". ...
Genetics that protects your heart
22 hours ago
(Medical Xpress)—Researchers have found a key piece of the puzzle as to why an isolated population in Greece may live healthy lives. They have found that a genetic variant known to protect the heart is ...
Genetic profiling tracks progression from manageable blood cancer into deadly disease
22 hours ago
Genetic profiling has painted the clearest picture yet of how a type of blood cancer – follicular lymphoma – develops and changes from a manageable disease into an aggressive cancer, offering new targets ...
Nonsense suppression drug restores function in a mouse model of aniridia
Dec 20, 2013
Congenital aniridia is a progressive disease that is associated with improper development of eye structures as well as abnormalities in the brain and pancreas. A variety of nonsense mutations in the PAX6 gene are linked with a ...
User comments
© Medical Xpress 2011-2013, Science X network
0 comments:
Post a Comment